EP Patent

EP2374448A1 — Oral film formulation

Assigned to Labtec GmbH · Expires 2011-10-12 · 15y expired

What this patent protects

Pharmaceutical composition comprising at least one triptan and at least one thiol-group containing reducing agent.

USPTO Abstract

Pharmaceutical composition comprising at least one triptan and at least one thiol-group containing reducing agent.

Drugs covered by this patent

Zofran (ondansetron) · GSK (originally Glaxo)

Patent Metadata

Patent number: EP2374448A1
Jurisdiction: EP
Classification: —
Expires: 2011-10-12
Drug substance claim: No
Drug product claim: No
Assignee: Labtec GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.